Source disclosure: February 13, 2026
Artra Group Corporation [6029.T]
TOKYO, Feb 13 (Pulse News Wire) – Artra Group Corporation (6029.T) reported its fiscal 2025 fourth quarter individual consolidated results, recording extraordinary income of ¥49 million due to loan loss reserve reversals and extraordinary losses of ¥83 million due to loan loss reserve provisions related to subsidiary debt. Additionally, the company's full-year consolidated performance exceeded previously disclosed estimates.
Compared to the forecast released on November 14, 2025, the final figures showed an increase in revenue of ¥130 million, operating profit of ¥19.5 million, ordinary profit of ¥18 million, and net profit attributable to parent shareholders of ¥58 million. Revenue was up 3.3%, operating profit rose 17.3%, ordinary profit increased 14.3%, and net profit grew 29.1%.
The positive variance was attributed to strong demand for new hospital memberships and contract transfers from competitors for Attra Claim Service Kaiin, along with robust sales of continued subscription services linked to the A-COMS system. In addition, efforts to expand the sale of new equipment used for self-pay treatments aimed at symptom improvement and preventive care contributed to higher sales ratios of new products.
As a result, annual revenues, operating profits, ordinary profits, and net profits surpassed the upwardly revised projections announced on November 14, 2025.
AI-translated content. 🟢 Confidence: High See terms • Original filing